Skip to content

Clinical trials

Terminated Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Terminated Country / region: United Kingdom Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20143
20171
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma2
Amgen1
Bellicum Pharmaceuticals1
Bristol-Myers Squibb1
Hoffmann-La Roche1
King's College Hospital NHS Trust1
MedImmune LLC1
University College, London1
University of Birmingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes4
Hematologic Neoplasms3
Lymphoma, Non-Hodgkin3
Burkitt Lymphoma2
Graft vs Host Disease2
Hodgkin Disease2
Leukemia2
Anemia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.